LINC02814

Across TCGA pan-cancer cohorts, LINC02814 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02814 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02814 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02814 expression acts as an unfavorable survival marker, although some lineages such as READ and LUAD show a favorable association.

ACC, READ, and COAD are the cancer types where LINC02814 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.271	0.657	<.001	56	view →
READ	OS	Median	IV	0.834	0.443	.003	20	view →
COAD	DFS	Median	All	0.714	0.830	.004	20	view →
LUAD	OS	Quartile	All	0.870	0.681	.006	15	view →
LGG	DFS	Quartile	All	0.889	0.726	.004	15	view →
LAML	DFS	Quartile	All	0.672	0.284	.007	14	view →
LIHC	OS	Quartile	III,IV	0.770	0.343	.008	13	view →
BLCA	DFS	Median	All	0.679	0.507	.018	10	view →
KIRC	DFS	Tertile	II,III,IV	0.794	0.666	.014	9	view →
PCPG	DFS	Tertile	All	0.505	0.893	.032	9	view →
STAD	OS	Quartile	All	0.345	0.492	.034	8	view →
UCEC	OS	Tertile	III,IV	0.894	0.770	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02814–ACC (DFS)

Open the ACC breakdown →